Skip to content
10-Q

Quarterly Report

DICE THERAPEUTICS, INC.

0000950170-22-016848

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 1, 2022 38.21M sh
Current Liabilities Q2 2022 · Jun 30, 2022 $12.07M
Current Liabilities Q2 2022 · Dec 31, 2021 $10.88M
Total Liabilities Q2 2022 · Jun 30, 2022 $24.65M
Total Liabilities Q2 2022 · Dec 31, 2021 $12.81M
Current Assets Q2 2022 · Jun 30, 2022 $284.88M
Current Assets Q2 2022 · Dec 31, 2021 $323.91M
Total Assets Q2 2022 · Jun 30, 2022 $302.58M
Total Assets Q2 2022 · Dec 31, 2021 $325.75M
Long Term Debt Q2 2022 · Dec 31, 2021 $1.92M
Short Term Debt Q2 2022 · Dec 31, 2021 $480K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $115.83M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $15.51M
Shares Diluted Q2 2022 · Jun 30, 2021 2.25M sh
Shares Diluted Q2 2022 · Jun 30, 2021 2.25M sh
Capex Q2 2022 · Jun 30, 2021 $401K
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$15.96M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$67.89M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$60.87M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$53.15M
Eps Diluted Q2 2022 · Jun 30, 2021 −$3.27
Eps Diluted Q2 2022 · Jun 30, 2021 −$6.86
Eps Basic Q2 2022 · Jun 30, 2021 −$3.27
Eps Basic Q2 2022 · Jun 30, 2021 −$6.86
Sga Expense Q2 2022 · Jun 30, 2021 $2.32M
Sga Expense Q2 2022 · Jun 30, 2021 $3.78M
Rd Expense Q2 2022 · Jun 30, 2021 $5.98M
Rd Expense Q2 2022 · Jun 30, 2021 $12.6M
Net Income Q2 2022 · Jun 30, 2021 −$7.36M
Net Income Q2 2022 · Jun 30, 2021 −$15.43M
Net Income Q2 2022 · Mar 31, 2021 −$8.07M
Operating Income Q2 2022 · Jun 30, 2021 −$7.17M
Operating Income Q2 2022 · Jun 30, 2021 −$15.26M
Revenue Q2 2022 · Jun 30, 2021 $1.13M
Revenue Q2 2022 · Jun 30, 2021 $1.13M